Goodbody Health Stock Fundamentals
Goodbody Health fundamentals help investors to digest information that contributes to Goodbody Health's financial success or failures. It also enables traders to predict the movement of Goodbody OTC Stock. The fundamental analysis module provides a way to measure Goodbody Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Goodbody Health otc stock.
Goodbody |
Goodbody Health OTC Stock Profit Margin Analysis
Goodbody Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Goodbody Health Profit Margin | (0.23) % |
Most of Goodbody Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Goodbody Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Goodbody Health has a Profit Margin of -0.2261%. This is 97.98% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 82.2% lower than that of the firm.
Goodbody Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Goodbody Health's current stock value. Our valuation model uses many indicators to compare Goodbody Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Goodbody Health competition to find correlations between indicators driving Goodbody Health's intrinsic value. More Info.Goodbody Health is rated # 4 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Goodbody Health's earnings, one of the primary drivers of an investment's value.Goodbody Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Goodbody Health's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Goodbody Health could also be used in its relative valuation, which is a method of valuing Goodbody Health by comparing valuation metrics of similar companies.Goodbody Health is currently under evaluation in profit margin category among its peers.
Goodbody Fundamentals
| Return On Equity | -0.56 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | (884.3 K) | |||
| Shares Outstanding | 36.5 M | |||
| Shares Owned By Insiders | 2.09 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 0.16 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 17.06 M | |||
| Gross Profit | 1.12 M | |||
| EBITDA | (13.74 K) | |||
| Net Income | (2.31 M) | |||
| Cash And Equivalents | 3.74 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 249.82 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 2.52 X | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | 1.86 M | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 0.35 | |||
| Beta | -1.24 | |||
| Market Capitalization | 2.64 M | |||
| Total Asset | 10.84 M | |||
| Z Score | 7.0 | |||
| Net Asset | 10.84 M |
About Goodbody Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Goodbody Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goodbody Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goodbody Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom. The company was formerly known as Sativa Wellness Group Inc. and changed its name to Goodbody Health Inc. in January 2022. Goodbody Health is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Goodbody OTC Stock
Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.